Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $22.9B |
| FY2017, ended Dec 31, 2017 | $19.2B |
| FY2018, ended Dec 31, 2018 | $22.3B |
| FY2019, ended Dec 31, 2019 | $21.8B |
| FY2020, ended Dec 31, 2020 | $13.8B |
| FY2021, ended Dec 31, 2021 | $14.2B |
| FY2022, ended Dec 31, 2022 | $12.3B |
| FY2023, ended Dec 31, 2023 | $13.5B |
| FY2024, ended Dec 31, 2024 | $31.8B |
| FY2025, ended Dec 31, 2025 | $36.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $36.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $36.6B |
| FY2017, ended Dec 31, 2017 | $37.8B |
| FY2018, ended Dec 31, 2018 | $41.3B |
| FY2019, ended Dec 31, 2019 | $43.3B |
| FY2020, ended Dec 31, 2020 | $15.4B |
| FY2021, ended Dec 31, 2021 | $24.6B |
| FY2022, ended Dec 31, 2022 | $45.0B |
| FY2023, ended Dec 31, 2023 | $53.7B |
| FY2024, ended Dec 31, 2024 | $57.1B |
| FY2025, ended Dec 31, 2025 | $59.1B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $65.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.23B | $2.32B |
| FY2017, ended Dec 31, 2017 | $2.14B | −$396M |
| FY2018, ended Dec 31, 2018 | $2.12B | $2.09B |
| FY2019, ended Dec 31, 2019 | $3.01B | $2.38B |
| FY2020, ended Dec 31, 2020 | −$7.07B | −$5.86B |
| FY2021, ended Dec 31, 2021 | −$1.96B | −$40.0M |
| FY2022, ended Dec 31, 2022 | $737M | $1.25B |
| FY2023, ended Dec 31, 2023 | $2.62B | −$260M |
| FY2024, ended Dec 31, 2024 | $3.15B | $3.83B |
| FY2025, ended Dec 31, 2025 | $3.35B | $2.56B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.58B | $1.12B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.18B |
| FY2017, ended Dec 31, 2017 | $1.48B |
| FY2018, ended Dec 31, 2018 | $1.69B |
| FY2019, ended Dec 31, 2019 | $2.76B |
| FY2020, ended Dec 31, 2020 | $11.3B |
| FY2021, ended Dec 31, 2021 | $18.3B |
| FY2022, ended Dec 31, 2022 | $7.17B |
| FY2023, ended Dec 31, 2023 | $6.06B |
| FY2024, ended Dec 31, 2024 | $8.77B |
| FY2025, ended Dec 31, 2025 | $5.94B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $6.65B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.8B |
| FY2017, ended Dec 31, 2017 | $13.3B |
| FY2018, ended Dec 31, 2018 | $13.4B |
| FY2019, ended Dec 31, 2019 | $14.6B |
| FY2020, ended Dec 31, 2020 | $26.7B |
| FY2021, ended Dec 31, 2021 | $33.4B |
| FY2022, ended Dec 31, 2022 | $31.2B |
| FY2023, ended Dec 31, 2023 | $29.1B |
| FY2024, ended Dec 31, 2024 | $24.7B |
| FY2025, ended Dec 31, 2025 | $21.3B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $26.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 3.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 315M |
| FY2017, ended Dec 31, 2017 | 285M |
| FY2018, ended Dec 31, 2018 | 267M |
| FY2019, ended Dec 31, 2019 | 248M |
| FY2020, ended Dec 31, 2020 | 318M |
| FY2021, ended Dec 31, 2021 | 325M |
| FY2022, ended Dec 31, 2022 | 327M |
| FY2023, ended Dec 31, 2023 | 328M |
| FY2024, ended Dec 31, 2024 | 327M |
| FY2025, ended Dec 31, 2025 | 323M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 325M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.61B | $70.0M | — |
| FY2017, ended Dec 31, 2017 | $1.84B | $73.0M | — |
| FY2018, ended Dec 31, 2018 | $1.24B | $101M | — |
| FY2019, ended Dec 31, 2019 | $1.65B | $100M | — |
| FY2020, ended Dec 31, 2020 | $353M | $108M | $1.10B |
| FY2021, ended Dec 31, 2021 | $0 | $238M | — |
| FY2022, ended Dec 31, 2022 | $0 | $89.0M | — |
| FY2023, ended Dec 31, 2023 | $0 | $80.0M | — |
| FY2024, ended Dec 31, 2024 | $162M | $142M | — |
| FY2025, ended Dec 31, 2025 | $637M | $148M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $54.0M | — | — |
Valuation
At current price- Market Cap
- $34.0B
- P/E
- 9.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.5×
- Price / Book
- 1.9×
- EV / EBITDA
- 6.7×
Growth
Trailing 12 months- Revenue (TTM)
- $65.6B
- Revenue Growth YoY
- 12.3%
- Revenue CAGR 3Y
- 9.5%
- Revenue CAGR 5Y
- 30.9%
- EPS Growth YoY
- 9.4%
- Net Income Growth YoY
- 8.6%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 7.5%
- Net Margin
- 5.5%
- FCF Margin
- 1.7%
- Return on Equity
- 22.3%
Earnings
Trailing 12 months- Net Income
- $3.58B
- EPS (diluted)
- $10.92
- EBITDA
- $7.97B
- Operating Income
- $4.92B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $6.65B
- Total Debt
- $26.4B
- Net Debt
- $19.8B
- Total Assets
- $85.1B
- Total Liabilities
- $67.4B
- Shareholders' Equity
- $17.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $8.16B
- Capital Expenditure
- $7.04B
- Free Cash Flow
- $1.12B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.30
Every ratio is calculated from the company’s reported figures.